KDS 2000

Drug Profile

KDS 2000

Alternative Names: Anandamide-topical

Latest Information Update: 09 Aug 2011

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Kadmus Pharmaceuticals
  • Class Anti-inflammatories; Antiemetics; Antihypertensives; Arachidonic acids; Bronchodilators; Cannabinoids; Eye disorder therapies; Muscle relaxants; Non-opioid analgesics; Polyunsaturated alkamides
  • Mechanism of Action Cannabinoid receptor CB1 antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Postherpetic neuralgia

Most Recent Events

  • 01 Mar 2004 Phase-II clinical trials in Neuropathic pain in USA (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top